SHH · 603439.SS
GuiZhou SanLi Pharmaceutical Co.,Ltd
CN¥10.61-CN¥0.13 (-1.21%)
GuiZhou SanLi Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.23% below the high.
Loading market information…
SHH · 603566.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Pulike Biological Engineering, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Pulike Biological Engineering, Inc.’s forward annual dividend is CN¥0.80 per share, paid semi-annual. The forward yield is 8.73% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Pulike Biological Engineering, Inc.’s next earnings report is currently expected on Apr 23, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Pulike Biological Engineering, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Pulike Biological Engineering, Inc. focuses on the entire lifecycle of animal health products, from scientific innovation and manufacturing to market distribution. The company provides a range of veterinary biologicals and pharmaceuticals, including specialized vaccines, antibodies, and medications developed for swine and poultry. Additionally, it produces various disinfectants. Its corporate headquarters are located in Luoyang, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥279.00M0.0% vs estimate |
| Q1 2025 | Apr 24, 2025 | -CN¥0.04 | CN¥281.00M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥10.61-CN¥0.13 (-1.21%)
GuiZhou SanLi Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.23% below the high.
CN¥27.85-CN¥0.87 (-3.03%)
Assure Tech (Hangzhou) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.11% below the high.
CN¥13.00-CN¥0.20 (-1.52%)
Beijing Scitop Bio-tech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.99% below the high.
CN¥14.80-CN¥0.66 (-4.27%)
Hefei Lifeon Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.21% below the high.
CN¥16.58-CN¥0.19 (-1.13%)
Hvsen Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.17% below the high.
CN¥9.21-CN¥0.44 (-4.56%)
Berry Genomics Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.07% below the high.
CN¥11.48-CN¥0.26 (-2.21%)
Qingdao Vland Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.64% below the high.
CN¥7.00-CN¥0.16 (-2.23%)
Shanghai Shen Lian Biomedical Corporation’s quoted price sits in the lower half of its reported 52-week range, 38.86% below the high.
